Piperazine-bisamide analogs were discovered as partial agonists of human growthhormonesecretagoguereceptor (GHSR) in a high throughput screen. The partial agonists were optimized for potency and converted into antagonists through structure–activity relationship (SAR) studies. The efforts also led to the identification of potent antagonist with favorable PK profile suitable as a tool compound for